This Heart Failure Pathway is to be used in conjunction with other pathways to assess and manage comorbidities. NOTE: Pregnant patients require pregnancy specific management – DO NOT use this pathway for pregnant patients.
Empirical treatment regimens for Acute Bacterial Osteomyelitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Acute Bacterial Osteomyelitis.
Empirical treatment regimens for Acute Infectious Diarrhoea/ Gastroenteritis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Acute infectious diarrhoea/ gastroenteritis cases.
Empirical treatment regimens for Acute otitis media based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Acute otitis media.
Empirical treatment regimens for Acute sinusitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Acute sinusitis.
Empirical treatment regimens for Bacterial eye infections (excluding trachoma) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Bacterial eye infections (excluding trachoma).
Empirical treatment regimens for bacterial meningitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover assessment and management of suspected bacterial meningitis.
Empirical treatment regimens for bronchitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected bronchitis.
Empirical treatment regimens for Burn Wound-related Infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Burn wound-related infections.
Empirical treatment regimens for Chlamydial urogenital infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Chlamydial urogenital infections.
Empirical treatment regimens for Community acquired pneumonia (mild) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Community acquired pneumonia (mild).
Empirical treatment regimens for Community-acquired Pneumonia – Severe based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Community-acquired Pneumonia – Severe cases.
Empirical treatment regimens for COPD Exacerbation based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of COPD Exacerbation.
Empirical treatment regimens for Enteric Fever based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Enteric Fever.
Empirical treatment regimens for Febrile Neutropenia based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Febrile Neutropenia.
Empirical treatment regimens for Gonococcal infection- sexually transmitted infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Gonococcal infection- sexually transmitted infections.
Empirical treatment regimens for Hospital-acquired Pneumonia based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Hospital-acquired pneumonia cases.
Impetigo / Erysipelas / Cellulitis -Skin and soft tissue infection
Empirical treatment regimens for Impetigo / Erysipelas / Cellulitis -Skin and soft tissue infection based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Impetigo / Erysipelas / Cellulitis–Skin and soft tissue infection.
Empirical treatment regimens for Intra-abdominal Infections – Acute Appendicitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Intra-abdominal infections – acute appendicitis cases.
Intra-abdominal Infections – Acute Cholecystitis and Cholangitis
Empirical treatment regimens for Intra-abdominal Infections – Acute Cholecystitis and Cholangitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected acute cholecystitis and cholangitis cases.
Empirical treatment regimens for Intra-abdominal Infections – Acute Diverticulitis in adults based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Intra-abdominal Infections – Acute Diverticulitis cases.
Empirical treatment regimens for Intra-abdominal Infections – Clostridioides difficile infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Clostridioides difficile infection.
Empirical treatment regimens for Intra-abdominal Infections – Pyogenic Liver Abscess based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Intra-abdominal infections – pyogenic liver abscess cases.
Empirical treatment regimens for Localized acute bacterial lymphadenitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Localized acute bacterial lymphadenitis.
Empirical treatment regimens for Lower urinary tract infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Lower urinary tract infections.
Empirical treatment regimens for Necrotizing Fasciitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Necrotizing Fasciitis.
Empirical treatment regimens for Oral and dental infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Oral and dental infections.
Empirical treatment regimens for Pharyngitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected pharyngitis.
Empirical treatment regimens for Pyomyositis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Pyomyositis.
Empirical treatment regimens for Sepsis in Adults (Including Septic Shock) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Sepsis in adults (including septic shock).
Empirical treatment regimens for Sepsis in Neonates (< 28 days) and Children (28 days–12 years) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Sepsis in Neonates and Children.
Empirical treatment regimens for Septic Arthritis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Septic Arthritis.
Empirical treatment regimens for Syphilis- sexually transmitted infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Syphilis- sexually transmitted infections.
Empirical treatment regimens for Trachoma based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Trachoma.
Empirical treatment regimens for Trichomoniasis- sexually transmitted infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Trichomoniasis- sexually transmitted infections.
Empirical treatment regimens for Upper Urinary Tract Infection based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Upper Urinary Tract Infection.
Empirical treatment regimens for Burn Wound and bite-related infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Wound and bite-related infections.